ArticleJournal of translational medicine2021

Heparin-binding growth factor (HDGF) drives radioresistance in breast cancer by activating the STAT3 signaling pathway.

Lingyun Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.